# Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)

Study · id `cardio:ct-nct06922994` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06922994](<https://clinicaltrials.gov/study/NCT06922994>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06922994

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 102 participants.

## Technical summary

Registry record NCT06922994. Randomized; quadruple masking; primary purpose treatment. Start 2025-03-31 (actual); primary completion 2026-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 102 participants (planned count; ClinicalTrials.gov record NCT06922994, source copy `cardio:ctgov-nct06922994-2026-10-26`, retrieved 2026-10-31)
- Started: 2025-03-31 (actual) (ClinicalTrials.gov record NCT06922994, source copy `cardio:ctgov-nct06922994-2026-10-26`, retrieved 2026-10-31)
- Primary completion: 2026-12-30 (anticipated) (ClinicalTrials.gov record NCT06922994, source copy `cardio:ctgov-nct06922994-2026-10-26`, retrieved 2026-10-31)
- Completion: 2026-12-30 (anticipated) (ClinicalTrials.gov record NCT06922994, source copy `cardio:ctgov-nct06922994-2026-10-26`, retrieved 2026-10-31)
- Countries: Italy (ClinicalTrials.gov record NCT06922994, source copy `cardio:ctgov-nct06922994-2026-10-26`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06922994-2026-10-26`, retrieved 2026-10-31)

## The registry's words

- Brief title: Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)
- Acronym: SEARCH
- Condition: Arrhythmogenic Cardiomyopathy
- Intervention (Drug): Atorvastatin 80 mg/day
- Intervention (Drug): Placebo atorvastatin
- Lead sponsor: Centro Cardiologico Monzino
- Lead sponsor class: OTHER
- Collaborator: Federico II University
- Collaborator class: OTHER
- Collaborator: Università Politecnica delle Marche
- Collaborator class: OTHER
- Collaborator: Ospedali dei Colli
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Centro Cardiologico Monzino (`cardio:org-centro-cardiologico-monzino`)
- Registry lists this organization as a collaborator: Federico II University (`cardio:org-federico-ii-university`)

## Provenance

Content hash: 2aa3583e6228dfbff0810ead709201c9bcf2a0216e4ed92f0ebb1248803b24ae
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
